Description
The REALQUALITY MERS-CoV is an IVD for the identification of MERS Coronavirus (MERS-CoV) in respiratory samples from patients with signs and symptoms of respiratory infection by Real-Time PCR
Product Characteristics
- The device is validated on RNA extracted from various samples types
- The assay requires only 5 µL of RNA extracted
- Validated on main Real time PCR instruments
- The automatic format of the assay can be used on used on GENEQUALITY® automatic platforms
- Easy interpretation of results with AB Genius Report software
Kit content
Kit content:
- Freeze-dried reagents for real time PCR amplification
- Extraction control (freeze-dried)
- Positive control (freeze-dried)
- Negative control
- Rehydration Buffer (solution to reconstitute the freeze-dried products)
- Water RNAse/DNAse free
Further Information
Coronaviruses (CoVs) positive-sense RNA viruses enclosed in an envelope.
Middle East respiratory syndrome (MERS) is a severe acute respiratory disease caused by the MERS coronavirus (MERS-CoV). It is a virus transferred to humans by camels and dromedaries: it is, in fact, a zoonotic virus, i.e. it is transmitted between animals and people and can be contracted through direct or indirect contact with infected animals.
The average age of MERS-CoV patients is approximately 50 years and patients are predominantly male. The infection tends to be more severe in elderly patients and in those with pre-existing conditions such as diabetes, chronic heart disease, or chronic kidney disease. MERS-CoV can be transmitted from person to person via direct contact, respiratory droplets (particles >5 micrometres), or aerosols (particles <5 micrometres). The clinical signs of MERS are variable, ranging from asymptomatic infection in 25% to severe disease with high mortality in the most significant risk groups, including older adults and patients with diabetes and heart disease, who are likely they will develop respiratory failure. The most common clinical symptoms of MERS are nonspecific, including myalgias, sore throat, and runny nose, with an incubation period of 2 to 14 days. Additionally, extrapulmonary manifestations include gastrointestinal disturbances. Neurological sequelae accompanied by respiratory symptoms have been reported in some cases. Leukopenia, thrombocytopenia, and anaemia are the most common laboratory disorders in patients infected with MERS.
Ordering Information
| Code | Product | PKG |
|---|---|---|
| RQ-145-4A | REALQUALITY MERS-CoV - Manual and automatic format | 48 tests |